The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver DiseasesNaga Chalasani, Arun J. Sanyal|Hepatology|2017Cited by 7.2k
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic SteatohepatitisArun J. Sanyal, Patricia R. Robuck, Naga Chalasani et al.|New England Journal of Medicine|2010Cited by 3.3k
A multisociety Delphi consensus statement on new fatty liver disease nomenclatureMary E. Rinella, Zobair M. Younossi, Miriam B. Vos et al.|Hepatology|2023Cited by 2.9k
A multisociety Delphi consensus statement on new fatty liver disease nomenclatureMary E. Rinella, Zobair M. Younossi, Jeffrey V. Lazarus et al.|Journal of Hepatology|2023Cited by 2.7k
Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of diseaseChris Estes, Arun J. Sanyal|Hepatology|2017Cited by 2.4k